A. Montag and Associates »

Stoke Therapeutics shares owned by A. Montag and Associates

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by A. Montag and Associates from 13F filings

Historical chart of A. Montag and Associates investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by A. Montag and Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by A. Montag and Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $10k 440 23.50
2025-06-30 $5.0k 440 11.35
2025-03-31 $2.9k 440 6.65

More positions owned by A. Montag and Associates

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Ishares Tr Rus 1000 Etf (IWB)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Home Depot (HD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Specialized Funds Div App Etf (VIG)
Broadcom Call Call Option (Principal) (AVGO)

View all positions for A. Montag and Associates

Top funds holding Stoke Therapeutics

FMR
BlackRock
Lynx1 Capital Management
Rtw Investments
Baker Bros. Advisors
Redmile Group
Morgan Stanley
Toronto-Dominion Bank
Vanguard Group
Skorpios Trust
Siren
BVF
State Street Corporation
Polar Capital Holdings
Point72 Asset Management

View all funds holding Stoke Therapeutics